Abstract 5072
Background
A key aim of neoadjuvant therapy in oes cancer is to increase the chance of complete R0 resection. Microscopic residual disease after surgery is reported in around 30% cases, mainly involving the circumferential resection margin (CRM), with current staging techniques unable to accurately identify pts at risk of residual tumour at the CRM. Previous small single site studies have shown that high res T2-weighted MRI achieves detailed imaging of oes anatomy and has the potential to serve as an additional non-invasive staging modality.
Methods
As part of the UK STO3 trial pts from participating centres with operable lower oes and type I/II OGJ adenoca were enrolled in the MRI observational sub-study. All pts underwent standard staging investigations, with additional MRI scans pre and post neoadjuvant chemo, followed by surgery. MRI parameters were consistent across sites and included CRM, T/N staging and apparent diffusion coefficient (ADC) assessment. Scans were reviewed locally and centrally to assess interobserver variability. Chemo response and association with pathological outcome were recorded.
Results
Between Aug 2011 and Mar 2015 57 pts were recruited from 11 sites. Of these 32 had matched pre and post chemo scans and 28 had corresponding pathological outcome data available. Negative CRM status was correctly identified on post chemo MRI in 17/19 (89%) cases; positive CRM in 3/9 (33%) cases. When compared to pathological staging there was concordance between MRI T staging in 36% cases, with overstaging in 43% and understaging in 21%. Concordance between MRI and CT for T/N staging was 66% and 77% respectively. Tumour size reductions and ADC increases were observed during chemo. Local sites predicted significantly more CRM involvement than central review (48 vs 19%).
Conclusions
This represents the first prospective, multi-centre, national trial of MRI in oes cancer and is the first report of interobserver variability between treatment centres. Although limited by small numbers, MRI showed promising specificity to identify negative surgical margins and reasonable correlation with pathological outcome. Discrepancy between local and central review was observed, suggesting that more standardised methods of MRI assessment in oes cancer are required.
Clinical trial identification
EudraCT: 2006-000811-12.
Legal entity responsible for the study
Medical Research Council, UK.
Funding
Cancer Research UK, Clinical Trials Awards Advisory Committee.
Editorial Acknowledgement
Disclosure
D. Cunningham: Research funding: Amgen, AstraZeneca, Bayer, Celgene, Merck-Serono, Medimmune, Merrimack, Novartis, Roche, Sanofi. N. Starling: Research funding: AZ, BMS, Merck; Honoraria: AZ. All other authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract